As a part of its “Speaking Out” video series, on behalf of the International Myeloma Foundation, CURE® spoke with their chief medical officer, Dr. Joseph Mikhael about the precursors to multiple ...

Birmingham researchers have received £230k of translational funding from Cancer Research Horizons to develop a prototype for a new test to monitor people at risk of developing the blood cancer ...

SWIFT-seq uses single-cell sequencing to profile CTCs, offering a noninvasive alternative to bone marrow biopsies for MM diagnosis and monitoring. The method provides comprehensive genomic and ...

Firefighters and recovery workers exposed to the aftermath of 9/11 in New York City had a higher occurrence of MGUS, a condition which may progress to myeloma, according to recent research. New York ...

Dear Dr. Roach: After a routine blood test raised suspicions, my husband was diagnosed with monoclonal gammopathy of undetermined significance (MGUS). At first, we thought this wasn’t a big deal, but ...